Genmab — Oktober 2017
-
Yes, et opkøb er nok det eneste som kan redde den positive kurstendens de sidste 2 år i indeværende år.
-
JNJ earnings presentation. Darzalex nævnt på side 10 http://files.shareholder.com/downloads/JNJ/1915508041x0x959899/BFE37E3C-99A1-454D-B8EE-D0E16CFB6046/JNJ_Earnings_Presentation_3Q2017.pdf
-
Ja tilbage til fremtiden... og virkeligheden... mon ikke kursen er hjemme nu... men husk nu allesammen at casen er god nok, så kursen skal nok komme op igen, når salg og indtjening berettiger til det, måske den med bjørnen og skindet alligevel passer ......
-
DARZALEX continued strong uptake in Quote fra presentation: "US and EU, especially 1 prior line setting, now launched in 25 countries in Europe."
-
Sydbank forventede 335 mio dollar i tredje kvartal. Det blev så 317. Forstår godt at Løntoft ikke er bekymret fremadrettet.
-
Quote fra presentation: "DARZALEX continued strong uptake in
US and EU, especially 1 prior line setting, now launched in 25 countries in Europe."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Velkommen til dit site! 